Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: A randomised clinical trial

Annals of the Rheumatic Diseases

Volumn 77, Issue 6, 2018, Pages 898-904

  Park, Jin Kyun ^a   Lee, Yun Jong ^b   Shin, Kichul ^c   Ha, You Jung ^b   Lee, Eun Young ^a   Song, Yeong Wook ^a   Choi, Yunhee ^d   Winthrop, Kevin L ^e   Lee, Eun Bong ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Seoul National University Boramae Hospital   (South Korea)

^d Seoul National University Hospital   (South Korea)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

discontinuation; influenza; methotrexate; rheumatoid arthritis; vaccination

Indexed keywords

ABATACEPT; GLUCOCORTICOID; HYDROXYCHLOROQUINE; INFLUENZA VACCINE; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PREDNISONE; RITUXIMAB; SALAZOSULFAPYRIDINE; TACROLIMUS; TOCILIZUMAB; TOFACITINIB; TUMOR NECROSIS FACTOR INHIBITOR; VIRUS ANTIGEN; ANTIRHEUMATIC AGENT; VIRUS ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG EFFICACY; DRUG RESPONSE; DRUG WITHDRAWAL; FEMALE; HEMAGGLUTINATION INHIBITION; HUMAN; IMMUNOGENICITY; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA VACCINATION; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; PARALLEL DESIGN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SEASONAL INFLUENZA; AGED; BIOSYNTHESIS; CLINICAL TRIAL; DEPRESCRIPTION; DRUG ADMINISTRATION; IMMUNOLOGY; INFLUENZA; INFLUENZA A VIRUS; INFLUENZAVIRUS B; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; SEASON; SINGLE BLIND PROCEDURE; VACCINATION; VACCINE IMMUNOGENICITY; YOUNG ADULT;

ADULT; AGED; ANTIBODIES, VIRAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DEPRESCRIPTIONS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOGENICITY, VACCINE; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; INFLUENZAVIRUS B; MALE; METHOTREXATE; MIDDLE AGED; PROSPECTIVE STUDIES; SEASONS; SINGLE-BLIND METHOD; VACCINATION; YOUNG ADULT;

EID: 85047250090     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2018-213222     Document Type: Article

References (23)

1. Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet 2016;388:2023-38.
2. Doran MF, Crowson CS, Pond GR, et al. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 2002;46:2287-93.
3. Saag KG, Teng GG, Patkar NM, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008;59:762-84.
4. van Assen S, Agmon-Levin N, Elkayam O, et al. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 2011;70:414-22.
5. Perry LM, Winthrop KL, Curtis JR. Vaccinations for rheumatoid arthritis. Curr Rheumatol Rep 2014;16:431.
6. Ribeiro AC, Guedes LK, Moraes JC, et al. Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice. Ann Rheum Dis 2011;70:2144-7.
7. Singh JA, Saag KG, Bridges SL, et al. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 2016;68:1-26.
8. Winthrop KL, Silverfield J, Racewicz A, et al. The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis. Ann Rheum Dis 2016;75:687-95.
9. Kapetanovic MC, Kristensen LE, Saxne T, et al. Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis. Arthritis Res Ther 2014;16:R2.
10. McMahan ZH, Bingham CO. Effects of biological and non-biological immunomodulatory therapies on the immunogenicity of vaccines in patients with rheumatic diseases. Arthritis Res Ther 2014;16:506.
11. Hua C, Barnetche T, Combe B, et al. Effect of methotrexate, anti-tumor necrosis factor α, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysis. Arthritis Care Res 2014;66:1016-26.
12. Park JK, Lee MA, Lee EY, et al. Effect of methotrexate discontinuation on efficacy of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial. Ann Rheum Dis 2017;76:1559-65.
13. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
14. Hannoun C, Megas F, Piercy J. Immunogenicity and protective efficacy of influenza vaccination. Virus Res 2004;103:133-8.
15. Monto AS, Gravenstein S, Elliott M, et al. Clinical signs and symptoms predicting influenza infection. Arch Intern Med 2000;160:3243-7.
16. van der Maas A, Lie E, Christensen R, et al. Construct and criterion validity of several proposed DAS28-based rheumatoid arthritis flare criteria: an OMERACT cohort validation study. Ann Rheum Dis 2013;72:1800-5.
17. Wolfe F, Mitchell DM, Sibley JT, et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481-94.
18. Gabay C, Bel M, Combescure C, et al. Impact of synthetic and biologic diseasemodifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study. Arthritis Rheum 2011;63:1486-96.
19. Gatherer D. The 2009 H1N1 influenza outbreak in its historical context. J Clin Virol 2009;45:174-8.
20. Centers for Disease Control and Prevention. Asian Lineage Avian Influenza A (H7N9) virus. 2017 https://www.cdc.gov/flu/avianflu/h7n9-virus.htm.
21. Prevention CfDCa. Highly pathogenic Asian Avian Influenza (H5N1) in people. 2017 https://www.cdc.gov/flu/avianflu/h5n1-people.htm.
22. Elkayam O, Amir S, Mendelson E, et al. Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases. Arthritis Care Res 2011;63:1062-7.
23. Stoffer MA, Schoels MM, Smolen JS, et al. Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update. Ann Rheum Dis 2016;75:16-22.